Skip to main content

Cardiac Assist Devices Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

 


Market Overview:

Cardiac assist devices are medical devices that have been specially designed for the patients suffering from cardiomyopathy, myelopathy, congenital heart disease, or peripheral arterial disease. These devices have been greatly useful in the treatment of patients who are unable to pump blood efficiently throughout the body due to a cardiac disorder or due to any other cardiac problem. Cardiac assist devices (CAD) are blood pumps that support the circulatory functions of severely ill cardiac patients. These pumps work along with the heart to improve the pumping efficiency and maintain optimum blood flow throughout the body. These devices are used to treat end-stage heart failure and are determined by the needs of the individual.

Competitive Landscape:

Major players operating in the global cardiacassist devices market are ABIOMED, Heart Ware International, Thoratec Corporation, Teleflex Incorporated, Berlin Heart GmbH, MAQUET GmbH & Co., and SynCardia Systems, Inc., among others.

Key Market Drivers:

High prevalence of cardiovascular diseases (CVDs) around the world is expected to aid in the growth of the cardiac assist devices market during the forecast period. For instance, as per the World Health Organization (WHO), cardiovascular diseases (CVDs) are one of the leading cause of death worldwide, taking an estimated 17.9 million lives each year.

Moreover, increasing adoption of cardiac assist devices in hospitals and homecare is expected to augment the growth of the cardiac assist devices market. For instance, in June 2021, Abbott announced the company has capacity and supply to effectively support the growing demand for mechanical circulatory support (MCS) devices for the effective treatment of advanced heart failure. Abbott is also supporting training and education programs for physicians who will now be offering Abbott's HeartMate 3 heart pumps to their patients.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...
Post a Comment
Read more